Similar companies
| Company | Stocktwits Subscribers | |
|---|---|---|
 |
Johnson & JohnsonJNJ |
49,548 0% |
 |
Eli Lilly and CompanyLLY |
34,965 0% |
 |
PfizerPFE |
106,455 0% |
 |
AstrazenecaAZN |
19,093 0% |
 |
AbbVieABBV |
32,961 0% |
Apimeds Pharmaceuticals Stocktwits Subscriber Count
Apimeds Pharmaceuticals (APUS) has 1,056 subscribers on Stocktwits, up 199.2% over the past three months. A growing subscriber base points to rising retail investor interest in the stock.
With 1,056 subscribers, Apimeds Pharmaceuticals has a smaller Stocktwits following than Johnson & Johnson (49,548) and Eli Lilly and Company (34,965).
Unlike daily Stocktwits mentions, which spike around news and earnings, subscriber count reflects sustained, long-term interest from the retail investor community.
How APUS’s Stocktwits Community Feeds the AI Score
Stocktwits subscriber count is a direct read on the size of the retail investor community tracking APUS. It is not a stock price on its own, but sustained growth in subscribers can reflect building retail interest. AltIndex feeds Apimeds Pharmaceuticals’s Stocktwits community into the APUS AI Score as one of 25+ alternative data signals, weighed against sentiment, Reddit activity, and fundamentals.
For daily discussion volume, see APUS Stocktwits mentions. For other retail-community metrics, see Reddit subscribers and Reddit mentions.
Month over Month
| Sep 2026 | 735 | |
| Aug 2026 | 715 | |
| Jul 2026 | 396 | |
| Jun 2026 | 362 | |
| May 2026 | 380 |
Apimeds Pharmaceuticals Stocktwits Subscribers: Frequently Asked Questions
Apimeds Pharmaceuticals (APUS) has 1,056 subscribers (1K) on Stocktwits, based on AltIndex’s tracking of the stock’s Stocktwits page.
Apimeds Pharmaceuticals's Stocktwits subscriber base is growing, up 199.2% over the past three months. View the trend chart above for the full history.
Stocktwits subscriber count is a proxy for the size of the retail investor community tracking a stock. Unlike daily mentions, which spike around news, subscriber growth reflects sustained interest. No single data point predicts a stock on its own, which is why AltIndex combines APUS’s Stocktwits community with sentiment, Reddit activity, and 20+ other signals in its AI Score rather than reading any one signal in isolation.
Apimeds Pharmaceuticals underperforms its industry peers when it comes to Stocktwits Subscribers, ranking in the 1st percentile.
StockTwits is a social media platform designed specifically for the investing community. It enables investors and traders to share market insights, strategies, and real-time news updates. Essentially, it's a specialized network for financial market discussions, often characterized by brief, tweet-like posts.
Sign up and get more insights on Apimeds Pharmaceuticals.
See Apimeds Pharmaceuticals’s complete stocktwits subscribers history
Sign up to unlock 1-year and all-time charts for APUS, plus 25+ alternative data signals, AI Scores, and real-time alerts.
Get Started for FREE
